Publisher Correction: Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications
A correction to this article has been published and is linked from the HTML version of this paper. The error has not been fixed in the paper.
Main Authors: | Isaac V. Cohen, Tigran Makunts, Rabia Atayee, Ruben Abagyan |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2017-12-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-14992-8 |
Similar Items
-
Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications
by: Isaac V. Cohen, et al.
Published: (2017-05-01) -
How can proton pump inhibitors damage central and peripheral nervous systems?
by: Tigran Makunts, et al.
Published: (2020-01-01) -
Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database
by: Isaac V. Cohen, et al.
Published: (2021-03-01) -
Anti-TNF-α therapy induced psoriasis in rheumatoid arthritis patients according to FDA postmarketing surveillance data
by: Haroutyun Joulfayan, et al.
Published: (2023-06-01) -
Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database
by: Tigran Makunts, et al.
Published: (2022-01-01)